There are about 8 million deaths each year from neglected tropical diseases
(NTDs) in the underdeveloped world, whilst drug discovery focus and practice is
only recently taking on greater urgency and embracing the latest technologies.
This unique book is a state of the art review of drug discovery in respect of
NTDs and highlights best practice to guide the ongoing drug discovery effort and
also to raise debate and awareness in areas that remain highly neglected. All
the major diseases such as malaria, trypanosomatids and TB are covered, with a
review of each disease and established compounds, new mechanistic classes and
new horizons. Each chapter highlights the